COVID-19 antiviral fails to reduce deaths or hospitalisations in high-risk vaccinated patients: NEJM study
The antiviral nirmatrelvir–ritonavir does not reduce hospitalisation or mortality rates in high-risk vaccinated patients with COVID-19, new research…